BKGI yields 2.41% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, BKGI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKGI + JNJ for your $10,000?
The fund seeks long-term total return, and also targets, but does not guarantee, an annualized gross forward-looking 12-month yield of 6% or more for its portfolio1 (the "targeted yield"). Generally, infrastructure assets (such as utilities, oil and gas pipelines, communication services and providers of these services) often contain inflation links* tied to the Consumer Price Index, which may help investors mitigate the erosive pressure of rising costs. The fund provides a differentiated infrastructure approach - focusing on both traditional (energy, industrials and utilities) and non-traditional infrastructure assets (communication services, health care and real estate), which can provide a broader opportunity set in the infrastructure space. Infrastructure exposure offers investors an additional equity allocation with a focus on defensive business models and quarterly dividend income. Liquid ETF structure allows investors to buy or sell any time the market is open.
Full BKGI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.